ÂÜÀòÂÒÂ×

Fabian Polyak is an accomplished professional in pharmaceutical technology and biopharmacy, currently serving as the Galenic Development Manager at HENNIG ARZNEIMITTEL GmbH & Co. KG since January 2022. Prior to this role, Fabian worked as a Wissenschaftlicher Mitarbeiter (Postdoktorand) at Ruprecht-Karls-Universität Heidelberg from October 2019 to December 2021, contributing to research in the Institute for Pharmacy and Molecular Biotechnology. Between February 2016 and September 2019, Fabian held the position of Projektmitarbeiter Galenik at Steinbeis-Transferzentrum Biopharmazie und Analytik and previously completed a doctorate at Ruprecht-Karls-Universität Heidelberg from February 2012 to January 2016. Educational qualifications include a Doktor der Naturwissenschaften in Pharmacy from Heidelberg University and specialized training as a Fachapotheker für Pharmazeutische Technologie.